STOCK TITAN

Aimei Health Technology Co. Unit (AFJKU) Financials

AFJKU NASDAQ
FY2025 annual
Revenue Not reported for FY2025
Net Income $1.1M -58.5% YoY
EPS (Diluted) Not reported for FY2025
Operating Cash Flow -$565K n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AFJKU SEC filings page.

This page shows Aimei Health Technology Co., Ltd Unit (AFJKU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AFJKU FY2025

The reported business has a shrinking asset base, worsening short-term coverage, and profits that do not translate into operating cash.

From FY2024 to FY2025, net income fell -58.5% while return on assets rose 5.3 pp, an unusual pairing that points to denominator shrinkage rather than stronger earnings. Total assets fell from $73.8M to $12.1M, so the improved return was produced against a much smaller base.

Positive net income fell from $2.6M in FY2024 to $1.1M in FY2025, while operating cash flow stayed negative. The supplied operating-cash-flow-to-net-income proportion worsened from -26.3% to -53.3%, showing earnings were becoming less cash-backed.

Liabilities exceeded assets in both years, rising from 102.0% of assets in FY2024 to 133.5% in FY2025. By FY2025, current liabilities were $3.4M against just $12.1M of total assets, leaving short-term coverage exceptionally thin.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Aimei Health Technology Co., Ltd Unit does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/5

Aimei Health Technology Co., Ltd Unit passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$83K
YoY-119.6%
QoQ-283.0%

Aimei Health Technology Co., Ltd Unit reported a net loss of $83K in Q2 2026. This represents a decrease of 119.6% from the same quarter a year earlier. Against the prior quarter it is down 283.0%.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$1K
YoY-31.4%
QoQ-92.1%

Aimei Health Technology Co., Ltd Unit held $1K in cash as of Q2 2026; no long-term debt figure is on record for that period.

Shares Outstanding
3M
QoQ0.0%

Aimei Health Technology Co., Ltd Unit had 3M shares outstanding in Q2 2026. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

AFJKU Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AFJKU quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Income-$192Kn/m-$62Kn/mN/A-$130Kn/m-$42Kn/m-$413Kn/mN/A-$200K
Income Tax$0n/m$0n/mN/A$0n/m$0n/m$0n/mN/A$0
Net Income-$83K-119.6%$45K-75.4%N/A$352K-52.7%$425K-30.2%$185K-75.6%N/A$744K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

AFJKU Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AFJKU quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$12.5M-71.9%$12.3M-71.8%$12.1M-83.6%$45.5M-37.5%$44.6M-38.0%$43.6M-38.8%$73.8M+4.7%$72.8M
Current Assets$44K-1.5%$19K+133.2%$3K-90.4%$25K-79.9%$45K-78.2%$8K-98.3%$30K-94.8%$124K
Cash & Equivalents$1K-31.4%$19K+152.1%$3K-89.6%$3K-97.1%$2K-98.6%$7K-98.2%$28K-95.1%$104K
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0
Total Liabilities$17.0M-64.1%$16.5M-64.1%$16.2M-78.5%$48.9M-33.5%$47.4M-34.6%$46.0M-35.8%$75.3M+6.6%$73.6M
Current Liabilities$3.8M+73.4%$3.5M+108.7%$3.4M+312.7%$2.8M+1102.1%$2.2M+1890.7%$1.7M+2048.2%$817K+3188.9%$231K
Non-Current Liabilities$13.2M-70.8%$13.0M-70.7%$12.8M-82.8%$46.1M-37.1%$45.2M-37.6%$44.3M-38.1%$74.5M+5.5%$73.4M
Total Equity-$4.5Mn/m-$4.2Mn/m-$4.1Mn/m-$3.4Mn/m-$2.9Mn/m-$2.4Mn/m-$1.5Mn/m-$797K
Retained Earnings-$4.5Mn/m-$4.2Mn/m-$4.1Mn/m-$3.4Mn/m-$2.9Mn/m-$2.4Mn/m-$1.5Mn/m-$797K

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

AFJKU Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AFJKU quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$157Kn/m-$75Kn/m-$43Kn/m-$96Kn/m-$202Kn/m-$224Kn/m-$195K-$54K
Investing Cash Flow-$103Kn/m-$69K-100.2%$33.7M-$450K-$450K$30.8MN/AN/A
Financing Cash Flow$243K-62.4%$159Kn/m-$33.6M$547K$647K-$30.6MN/AN/A
Share BuybacksN/AN/A$34.1M$0$0$31.3MN/AN/A

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.

AFJKU Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AFJKU quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Assets-0.7%-1.6pp0.4%0.0ppN/A0.8%-0.3pp0.9%+0.1pp0.4%-0.6ppN/A1.0%
Current Ratio0.010.0x0.010.0x0.000.0x0.01-0.5x0.02-1.8x0.00-6.1x0.04-23.3x0.54

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$4.1M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Aimei Health Technology Co., Ltd Unit AFJKU FY2025 N/A $1.1M N/A N/A —
Oaktree Acquisition Corp. III Life Sciences Unit OACCU FY2025 N/A $7.3M N/A N/A —
Centurion Acquisition Corp. Unit ALFUU FY2025 N/A $11.7M N/A N/A —
Cayson Acquisition Corp Unit CAPNU FY2025 $4.9M $3.0M 62.0% N/A 36/100

Frequently Asked Questions

Is Aimei Health Technology Co., Ltd Unit profitable?

Yes, Aimei Health Technology Co., Ltd Unit (AFJKU) reported a net income of $1.1M in fiscal year 2025.

What is Aimei Health Technology Co., Ltd Unit's operating cash flow?

Aimei Health Technology Co., Ltd Unit (AFJKU) recorded an outflow of $565K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Aimei Health Technology Co., Ltd Unit's total assets?

Aimei Health Technology Co., Ltd Unit (AFJKU) had $12.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Aimei Health Technology Co., Ltd Unit (AFJKU) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Aimei Health Technology Co., Ltd Unit (AFJKU) had a return on assets of 8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Aimei Health Technology Co., Ltd Unit (AFJKU) has negative shareholder equity of -$4.1M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Aimei Health Technology Co., Ltd Unit (AFJKU) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Back to top